Edition:
India

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

68.80CHF
16 Jan 2018
Change (% chg)

CHF0.40 (+0.58%)
Prev Close
CHF68.40
Open
CHF68.70
Day's High
CHF69.40
Day's Low
CHF68.65
Volume
59,831
Avg. Vol
106,286
52-wk High
CHF69.65
52-wk Low
CHF52.05

Chart for

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.16
Market Cap(Mil.): CHF3,731.19
Shares Outstanding(Mil.): 55.40
Dividend: 2.75
Yield (%): 4.08

Financials

BRIEF-BB Biotech Reports 5.6% Passive Stake In Voyager Therapeutics

* BB BIOTECH AG REPORTS 5.6% PASSIVE STAKE IN VOYAGER THERAPEUTICS AS OF JAN 3 - SEC FILING‍​ Source text: (http://bit.ly/2CZEeZD) Further company coverage:

10 Jan 2018

BRIEF-BB Biotech Q3 net profit down at CHF 365 million

* PRODUCT APPROVALS AND SOLID COMPANY RESULTS LEAD THE BIOTECH SECTOR HIGHER

20 Oct 2017

BRIEF-BB Biotech reports 5.1 pct passive stake in Intra-Cellular Therapies

* BB Biotech AG reports 5.1 percent passive stake in Intra-Cellular Therapies Inc as of August 18, 2017 - SEC filing‍​ Source text: (http://bit.ly/2xcLrz4) Further company coverage:

23 Aug 2017

BRIEF-BB Biotech H1 net result turns to profit of CHF 478 mln

* ‍CONSEQUENTLY, H1 2017 NET INCOME AMOUNTED TO CHF 478 MN, COMPARED TO A LOSS OF CHF 1 170 MN FOR H1 2016​

21 Jul 2017

Earnings vs. Estimates